MLPH.US Molecular Pharmacology (USA) Ltd

Financial Services Biotechnology USA Stocks
0.0202 USD
Close of Jul 25, 2026
0.0100 0.4850
Market cap
USD 404K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is MLPH.US undervalued?

Graham number

The Graham number of Molecular Pharmacology (USA) Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Molecular Pharmacology (USA) Ltd fundamental analysis

No fundamental analysis for Molecular Pharmacology (USA) Ltd yet.

Molecular Pharmacology (USA) Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Molecular Pharmacology (USA) Ltd

AI Energy Inc., a development stage company, focuses on discovery and development of analgesic and anti-inflammatory products based on the proprietary MPL-TL (tripeptofen) compound. The company was formerly known as Molecular Pharmacology (USA), Ltd. and changed its name to AI Energy Inc. in April 2026. The company is based in Shanghai, China.

Full company profile